Introduction {#s1}
============

Infective endocarditis (IE) extols a high cost for society worldwide, with a US incidence of 10,000 to 15,000 cases each year\[[@B1]\]. IE is associated with prolonged hospitalization, can require surgery\[[@B2]\], and impairs quality of life\[[@B3]\]. IE was initially described in 1885 by Osler\[[@B4]\] as a disease of patients with pre-existing valvular abnormalities. Since then, notable improvements in IE diagnosis and treatment have been made. However, in-hospital mortality is still close to 20 percent\[[@B5],[@B6]\].

Risk factors for IE have changed over time. There have been widespread changes in health-care delivery in the last five decades, which have impacted the clinical spectrum of IE. These include the use of intracardiac devices\[[@B7]\], prosthetic valves\[[@B8]\], hemodialysis\[[@B9]\], and an increase in the elderly population\[[@B10]\]. Furthermore, changes in antibiotics have led to alterations in patterns of infection and bacterial resistance in both the US\[[@B11],[@B12]\] and Europe\[[@B13]\].

In recent decades, several studies have noted an increase in the proportion of IE caused by staphylococcal species\[[@B14],[@B15]\]. However, others have not\[[@B16]\]. A systematic review of population-based studies including 15 studies and 2,371 cases found no significant changes in the causative organism over time\[[@B17]\]. However, significant limitations were present in this study, including a low power to detect changes; nor did it cover the last decade. Moreover, to the best of our knowledge, there are no systematic reviews of hospital based studies.

Proper understanding of IE epidemiology is paramount, as different organisms produce varied complications and may require different treatment and prophylaxis\[[@B18]\]. The objective of this research was to assess whether there have been changes in IE epidemiology globally over the last half century. Towards this end, we performed a systematic review of both population and hospital-based studies.

Methods {#s2}
=======

Data Sources and Searches {#s2.1}
-------------------------

We searched, with no language restrictions, PubMed, OVID/MEDLINE and EMBASE electronic databases from their inception to December 2011, for studies reporting infective endocarditis microbiology. We used the term 'infective endocarditis' for the Mesh keyword. Date last search performed was December 1^st^, 2011. We supplemented the search with references from articles reviewed and correspondence with other researchers, including experts in the field. When a reference was deemed potentially suitable for inclusion, a full-text copy was obtained and reviewed according to predefined criteria (listed below). We followed the PRISMA guidelines for systematic reviews.

Study Selection and Data Collection {#s2.2}
-----------------------------------

Prospective and nonprospective studies reporting the frequency distribution of infective endocarditis in the last five decades were included in this systematic review. Two investigators had the protocol for study selection (LS and CD) and independently assessed the studies for eligibility. Inclusion criteria were: (1) a clear definition of the population studied; (2) a clear definition of the time period; (3) a clear definition of infective endocarditis; and (4) a clear description of the frequency distribution of the microbiology encountered. In order to avoid bias, we excluded studies limited to specific populations (e.g. HIV or intravenous drug users). When there was difference of opinion, a third investigator (NC) resolved the disagreement. The authors are fluent in English, Spanish, Portuguese, and Italian; papers in other languages were translated by collaborating physicians who were native speakers. When two studies reported data from the same cohort and time frame, only the most complete one was included. If a study reported data for various time frames, data were analyzed separately for each decade. Kappa (k) for inclusion was calculated from a sample of 10 randomly selected papers. Results were compared and inconsistencies were resolved by consensus. Dr. Andrew Wang from Duke University was consulted for reviewing the list of included studies for completeness.

For each study included, the following information was extracted: first author's last name, journal, year of publication, IE definition used, certainty (possible IE vs. definite IE), countries, time-frame, multi-center vs. single center, sample size, age, gender, mortality, intravenous drug abuse (IVDA), intracardiac device or prosthetic valve, *Staphylococcus aureus* (SA), coagulase-negative staphylococcus (CNS), enterococci, Streptococcus viridans (SV) and culture negative (CN) IE.

We also included patients from Einstein Medical Center (EMC), a tertiary 440-bed city hospital in Philadelphia, PA, US; for the years 2000 - 2010. Data were retrospectively extracted per ICD code and then included only if patients met 'definite' or 'possible' modified Duke criteria\[[@B19]\]. Clinical characteristics were extracted for each patient as mentioned above. This data was added as one more study to the last decade. Sensitivity analyses showed that subtracting this data from the rest did not modify results significance.

Quality assessment {#s2.3}
------------------

Two reviewers (LS and CD) independently assessed the quality of the manuscripts using the approaches recommended by Khan and colleagues\[[@B20]\] and Stroup and colleagues\[[@B21]\] for cohort studies. The main criteria were: (1) prospective study, (2) Duke or Von Reyn definition of IE, (3) definite IE, and (4) number of patients above 40. Quality was assigned as A, or excellent, with 4 points, B or good, with 2-3 points, and C, or suboptimal, with 0-1 points. Data was weighted for quality for SA and SV without affecting results statistical significance.

Statistical analysis {#s2.4}
--------------------

Data were extracted independently by two researchers (LS and CD) and collected on an Excel spreadsheet. Data were allocated to a decade according to the midpoint date for the time frame studied. For example if the time frame was 1979 to 1983, data was assigned to the 80s. Results are shown as mean +/- SD, percentages for each decade, and the 95% CI. Main variables studied were the frequency distribution of pathogens, patient age and gender, and in-hospital mortality. ANOVA and Chi^2^ test were used to compare studies by decades. Each group was compared to the rest using paired Students t-tests. Samples were weighted for size. Results from our own hospital were included in the last decade and weighted for size. Sensitivity analysis showed that subtracting this data did not affect results statistic significance. Moreover subtracting the biggest study by Murdoch et al. from the International Collaboration on Endocarditis did not affect statistical significance of results. Sub-analyses were performed for continent and IVDA. Correlation between IVDA and SA was performed using Spearman correlation test. Hospital-based studies and population-based studies were included. As both types of studies may be prone to bias (hospital-based studies to referral bias\[[@B22]\] and population-based studies to selection bias) hospital-based and population-based studies were analyzed separately. Sensitivity analyses were performed for size, single vs multi-center and quality without affecting significance of results. A p\<0.05 was considered statistically significant. Analyses were performed using JMP version 10.0 (SAS Institute, Cary, NC, US).

Data were presented in a graph as mean (in green, centerline of diamond) and variance (size of diamond) for each variable studied in each decade, with standard deviations (blue). Each dot in a column represents a particular study percentage. N below decades represents total number of patients in each decade. Every patient included in each study was diagnosed with IE as described above.

Results {#s3}
=======

Candidate studies included 24,415 articles identified in PubMed, 10,421 in Medline, and 4,528 in EMBASE; one hundred sixty studies met all inclusion criteria (see flow diagram in [Figure 1](#pone-0082665-g001){ref-type="fig"}). Of these, 142 were hospital-based, including a total of 23,606 patients ([Table 1](#pone-0082665-t001){ref-type="table"}), and 18 were population-based, including a total of 3,477 patients ([Table 2](#pone-0082665-t002){ref-type="table"}). Investigators (LS and CD) were in agreement on which articles were to be included (k=1).

![Flowchart of the selection process.](pone.0082665.g001){#pone-0082665-g001}
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###### Characteristics of hospital-based studies included.

  **Author**                   **N**   **De**   **Definition**           **Cert**   **Age**   **Male**   **SA**   **SV**   **CNS**   **Ent**   **CN**   **Mort**   **IVDA**   **Prosthetic**   **Year**   **Country**    **Quality**
  ---------------------------- ------- -------- ------------------------ ---------- --------- ---------- -------- -------- --------- --------- -------- ---------- ---------- ---------------- ---------- -------------- -------------
  Agüero\[[@B33]\]             25      R        Pelletier                NR         NR        NR         12       40                           12                                              77-80      Chile          C
  AIPEI\[[@B34]\]              390     P        Duke                     Def        60        71         23       16       6         7         5        17         6          16               99         France         A
  Ako\[[@B35]\]                69      R        Duke                     Pos        55        72         15       38                 10        25       19         0          33               90-99      Tokyo          B
  Ako\[[@B35]\]                125     R        Duke                     Pos        46        70         6        45                 6                  25         0          16               80-90      Japan          B
  Allal\[[@B36]\]              101     R        Other                    N/A        56        70         18       11                 9         17                             4                66-82      France         C
  Al-Tawfiq\[[@B37]\]          54      R        Mod Duke                 Def        60        68         43       17       7         22                 29                    19               95-08      Saudi Arabia   B
  Auger\[[@B38]\]              50      R        Pelletier                Pos        43                   6        28                           14                                              69-77      Canada         C
  Avanekar\[[@B39]\]           600     P        Mod Duke                 NR         63        67         22       32       7         10                                       34               80-98      USA            B
  Bailey\[[@B40]\]             210     R        Hickie                   N/A        43        70         14       25                           30       31         0          8                62-71      Australia      C
  Barrau\[[@B41]\]             170     P        Mod Duke                 Def        65        74         13       18       7         10        11                  3          41               14-00      France         A
  Bennis\[[@B42]\]             157     R        Other                    N/A        28        63         4                 11                  22                             4                83-94      Morocco        C
  Bishara\[[@B43]\]            252     R        Mod Duke                 Pos        62        54         24       32       11        6         25       16         0          23               87-96      Israel         B
  Borer\[[@B44]\]              71      R        Duke                     Pos        50        55         4        18                 18        8        17         1          27               80-94      Israel         B
  Bouramoue\[[@B45]\]          32      R        Von Reyn                 Pos                             19                                    41                                              76-89      Congo          B
  Bouza\[[@B46]\]              109     P        VReyn/Steckelberg/Duke   Pos        50        73         45       9        14        9         10                  36         17               94-96      Spain          B
  Braun\[[@B47]\]              261     P        Von Reyn/Duke            Pos        49        69         18       31                 10        23       16                    28               80-99      Chile          B
  Buchholtz\[[@B48]\]          235     P        Mod Duke                 Pos        61        70         22                9         18        12       15         6          25               02-05      Denmark        B
  Cabell\[[@B49]\]             329     P        Duke                     Pos        57        54         40       11       9         10        10                  8          27               93-99      USA            B
  Casabe\[[@B50]\]             294     P        Duke                     Pos        51        70         26       31       2         11        20       24         14         9                92-93      Argentina      B
  Cecchii\[[@B51]\]            147     P        Mod Duke                 Def                             19       18       8                   25       14         10         25               00-01      Italy          A
  Cetinkaya\[[@B52]\]          189     R        Mod Duke/Von Reyn        NR         36        66         12       8        5         6         50                  0          20               74-99      Turkey         B
  Chao\[[@B53]\]               88      R        Duke                     Pos        41        67         32       17       2         3         20       25         24         8                90-97      Taiwan         B
  Chen\[[@B54]\]               58      R        Duke                     Def        41        79         21       55       9         3         5                                               87-98      Taiwan         B
  Chen\[[@B55]\]               178     R        Von Reyn                 Pos        62                   39       27                 6                                        25               79-91      Australia      B
  Cheng\[[@B56]\]              101     R        Other                    Pos        39                   8        53                 4         14                                              79-87      Taiwan         C
  Choudhury\[[@B57]\]          190     R        Other                    N/A        25        70         17       8        3         2         54       25                    1                81-91      India          C
  Chu\[[@B58]\]                65      R        Duke                     Pos        68        29         31       25       2         5         23       20                    23               97-02      NZ             B
  Cicalini\[[@B59]\]           151     R        Duke                     Def        44        69         42       19       8         7         17                  60         11               92-03      Italy          B
  Cicalini\[[@B59]\]           132     R        Duke                     Def        36        65         44       23       6         5         15                  58         12               80-91      Italy          B
  Corral\[[@B60]\]             550     R        Mod Duke                 Pos        51        73         44       15       12        5         8                   41                          85-02      Spain          B
  Couturier\[[@B61]\]          66      R        Duke/Von Reyn            Def        57        65         26                          6         20                  5          14               92-98      France         B
  Deprele\[[@B62]\]            80      R        Duke                     NR         65        70         7        21       6         11        11                             10               95-01      France         B
  Di Salvo\[[@B63]\]           178     R        Duke                     Def        57        75                                     5         12       11         3          26               93-00      France         B
  Durack\[[@B64]\]             204     R        Duke                     Def        48        51         37       23       7         7         3        21         28         31               85-92      USA            B
  Dwyer\[[@B65]\]              193     R        Von Reyn                 Pos        51        65         39       26       5         5         10                  9          22               79-92      Australia      B
  Dyson\[[@B66]\]              128     R        Other                    N/A        53        70         11       38       15        13        5        17         0          39               87-96      UK             C
  Fedorova\[[@B67]\]           112     R        Duke                     NR         51        65         23                          4         41       26         15         3                00-07      Russia         B
  Fefer\[[@B68]\]              108     R        Duke/Von Reyn            Pos        57        56         13       31       7         11        18       11                    31               90-99      Israel         B
  Ferreiros\[[@B69]\]          390     P        Mod Duke                 Def        59        70         28       25       6         10        11       25         4          16               01-02      Argentina      A
  Finland\[[@B70]\]            78      R        Other                    N/A                             31       18                 9                                                         60-64      USA            C
  Garvey\[[@B71]\]             165     R        Other                    N/A                  56         14       32       6                   16       30         7          20               68-73      USA            C
  Gergaud\[[@B72]\]            53      R        Von Reyn                 Pos        66        66         11       19       4         11        15                  13         17               83-90      France         B
  Giannitsioti\[[@B73]\]       195     P        Mod Duke                 Pos        64        65         17       21       10        20        10       20         7          22               00-04      Greece         B
  Gossius\[[@B74]\]            46      R        Von Reyn                 Pos                             37       20       13        4         20                             17               72-81      Norway         B
  Gotsman\[[@B75]\]            100     R        Duke                     Def        55        55         17       22       5         4         12       8          1          24               91-00      Israel         B
  Gracey\[[@B76]\]             49      R        Other                    N/A        39                   14       49                                                                           60-65      Australia      C
  Haddy\[[@B77]\]              23      R        Cherubin                 N/A                             39                                    0                                               73-79      USA            C
  Haddy\[[@B77]\]              43      R        Cherubin                 N/A                             7                                     16                                              64-73      USA            C
  Hammami\[[@B78]\]            72      R        Duke                     Def        32        56         18       17       6         1                                        67               97-00      Tunisia        B
  Heiro\[[@B79]\]              95      R        Duke                     Pos        55        70         33       20       8         6         18                  26         16               00-04      Finland        B
  Heiro\[[@B79]\]              125     R        Duke                     Pos        58        72         24       22       10        6         29       11         5          20               90-99      Finland        B
  Heiro\[[@B79]\]              106     R        Duke                     Pos        51        56         13       19       9         14        34                  0          26               80-89      Finland        B
  Heper\[[@B80]\]              74      R        Other                    N/A        25        66         14       19       15        10                 18                    14               95-99      Turkey         C
  Hermida Amej\[[@B81]\]       87      R        Mod Duke                 Def        55        76         44       18       7         8         2                   30                          89-03      Spain          B
  Hill\[[@B82]\]               203     P        Mod Duke                 Def        67        60         31       12       11        17        11                  1          34               00-04      Belgium        A
  Hricak\[[@B83]\]             190     P        Duke/Von Reyn            Pos                                      16                 6         33                                              02-06      Slovakia       B
  Hricak\[[@B83]\]             339     P        Duke/Von Reyn            Pos                                      15                 7         41                                              91-01      Slovakia       B
  Hricak\[[@B83]\]             75      P        Duke/Von Reyn            Pos                                      15                 12        11                  0                           84-90      Slovakia       B
  Hsu\[[@B84]\]                315     R        Mod Duke                 Pos        51        59                  22       6         5         20                  4          8                95-03      Taiwan         B
  Huang\[[@B85]\]              72      R        Mod Duke                 Pos        58        50         35                4         3         25       30         19         4                03-06      Taiwan         B
  Husebye\[[@B86]\]            68      R        Duke                     Def        58        69         38       21       4         3         12       34         10         18               88-94      Norway         B
  Jaffe\[[@B87]\]              70      R        Other                    N/A        47        57         34       26       3         9         10       10         29         16               83-88      USA            C
  Jain\[[@B88]\]               247     R        Mod Duke                 Pos                  71         57       19       5         4         5        15         75         3                96-03      USA            B
  Jalal\[[@B89]\]              466     R        Other                    N/A        23        59         12       10       2         0         68                             1                82-97      India          C
  Julander\[[@B90]\]           217     R        Other                    N/A                             39       23       2         4                             27                          65-80      Sweden         C
  Kanafani\[[@B91]\]           89      R        Mod Duke                 Pos        48        64\.       20       20       8         3         22       18         0          20               86-01      Lebanon        B
  Kazanjian\[[@B92]\]          60      P        Pelletier/Von Reyn       NR         62        57         27       15       10        8         5                   28         7                84-89      USA            B
  Khanal\[[@B93]\]             46      NR       Duke                     Def        26        57         11       13       2                            40                    2                95-97      India          B
  Kim\[[@B94]\]                56      R        Von Reyn                 Pos        52        71         14       47       5         4                  20         7          23               75-87      USA (HI)       B
  King\[[@B95]\]               30      R        Pelletier                Pos        45        60         10       23                           17                             10               80-82      USA            C
  King\[[@B95]\]               13      R        Pelletier                Pos        44        46         8        54                           15                             0                70-72      USA            C
  Kiwan\[[@B96]\]              60      P        Other                    N/A        28                   12       32                                                          7                85-88      Kuwait         B
  Knudsen\[[@B97]\]            51      P        Mod Duke                 NR         58        75         25       31       8         16        8        16         6          6                00-01      Denmark        B
  Knudsen\[[@B97]\]            121     P        Mod Duke                 NR         64        78         25       25       15        15        9        22         3          45               05-06      Denmark        B
  Koegelenberg\[[@B98]\]       60      P        Duke                     Pos        38        58         2        10       3         2         65                  0          167              97-00      South Africa   B
  Koga\[[@B99]\]               55      R        Other                    N/A                             9        22                           11       36                    20               75-83      Japan          C
  Krecki\[100\]                69      R        Duke                     Def        52        59         10                          7         41       39                    10               92-05      Poland         B
  Kurland\[[@B101]\]           154     R        Other                    N/A        54        44         27       24       7         7         23       14         4          12               83-92      Sweden         C
  Leblebicioglu\[[@B102]\]     112     P        Mod Duke                 Pos        45        50         35       29       15        16        16                  8          17               00-04      Turkey         B
  Lederman\[[@B103]\]          123     R        Mod Von Reyn             NR         42        55         23       34       6         6         6        10         29         10               72-84      USA            B
  Leitersdorf\[[@B104]\]       92      R        Pelletier                NR         43                   14       37       5                   21                             33               70-80      Israel         C
  Letaief\[[@B105]\]           440     P        Mod Duke                 Pos        32        55         12       11       6         4         50       21         0          17               91-00      Tunisia        B
  Lien\[[@B106]\]              72      R        Pelletier/Von Reyn       Prob       55        58         21       33       4         4         18                  0          10               73-84      Norway         C
  Lode\[[@B107]\]              103     P        Other                    N/A        46        54         12                          12                            3          9                71-81      Germany        B
  Lopez-Dupla\[[@B108]\]       120     R        Mod Duke                 Pos        51        68         33       24       10        6         13       19         25         6                90-04      Spain          B
  Lou\[[@B109]\]               120     R        Duke                     NR         43        66                                               37                                              97-07      China          B
  Loupa\[110\]                 101     P        Duke                     Pos        55        70         22       19       16        3         18                  3          31               97-00      Greece         B
  Lowes\[[@B111]\]             60      R        Other                    N/A                  60         7        52       2         12        25                  2          3                66-75      UK             C
  Lupis\[[@B112]\]             36      R        Mod Duke                 Def        54        56         8                           11        58                  8                           03-06      Italy          B
  Manzano\[[@B113]\]           586     P        Duke                     NR                              18       16       16        8         14                  5          39               95-05      Spain          B
  Math\[[@B114]\]              104     P        Mod Duke                 Def        24        71         7        7                  5         66       26         0          23               04-06      India          A
  Meirino\[[@B115]\]           131     R        Other                    N/A        35        51         14       45                                    28         2          33               90-94      Mexico         C
  Mesa\[[@B116]\]              145     R        Other                    N/A        42        62         25       20       12                  24                  24         37               78-87      Spain          C
  Mills\[[@B117]\]             144     R        Vogler                   N/A        45        66         24       36       1         7         17       30         19                          63-71      USA            C
  Morelli\[[@B118]\]           13      R        Other                    N/A        58        62         0        46       0         23        31       8          8          31               91-93      Italy          C
  Mouly\[[@B119]\]             90      R        Duke                     Pos        60        67         31       8        13        8         12       20         8          25               97-98      France         B
  Murdoch\[[@B120]\]           2781    P        Mod Duke                 Def        58        68         31       17       11        10        10       18         10         22               00-05      Multicenter    A
  Nadji\[[@B121]\]             310     P        Duke                     Def        60        74         23                7         10        19                             13               90-03      France         A
  Nakamura\[[@B122]\]          93      R        Other                    N/A        34        58         8        47                           24                                              76-81      Japan          C
  Nashmi\[[@B123]\]            47      R        Mod Duke                 Def        32        59         24       11       17        13        26       9          4          21               93-03      S. Arabia      B
  Netzer\[[@B124]\]            125     R        Duke                     Pos                             24                10        35        7        14         13         17               88-95      Switzerland    B
  Netzer\[[@B124]\]            87      R        Duke                     Pos                             21       26       12                  9        16         7          17               80-87      Switzerland    B
  Nigro\[[@B125]\]             18      R        Duke                     Pos        43        72         22       11                           28                             33               96-99      Italy          C
  Nihoyannopoulos\[[@B126]\]   109     R        Other                    N/A        43        55         16                                    14                             29               68-82      UK             C
  Nunes\[[@B127]\]             62      P        Mod Duke                 Pos        45        63         21                10        10        36       31                    31               01-08      Brazil         B
  Okada\[[@B128]\]             28      R        Duke                     Def        45        46         0        50       0         11        7                              7                87-97      Japan          B
  Olaison\[[@B129]\]           161     P        Duke/Von Reyn            NR         60        50         27       23       5         7         22       10         4          16               84-88      Sweden         B
  Olds\[[@B130]\]              43      R        Von Reyn                 Pos                  61         17       17       5                   7                              24               85-89      USA            B
  Ordonez\[[@B131]\]           85      P        Duke                     Def        43        71         22                          6         28                  32         24               92-96      Spain          A
  Pachirat\[[@B132]\]          160     R        Duke                     Pos        39        66         16       23                 6         38       25         8          5                90-99      Thailand       B
  Pazdernik\[[@B133]\]         117     R        Mod Duke                 Def        60        73         31       9        7         13        18       19         1          18               98-06      Czech Rep      B
  Peat\[[@B134]\]              78      R        Von Reyn                 Pos        50        54         21       53       6         1                  24                    21               76-86      NZ             B
  Pelletier\[[@B135]\]         125     R        Pelletier                Pos        43        77         30                5         10        10                  15         10               63-72      USA            C
  Proenca\[[@B136]\]           65      R        Duke                     Def                             54       3        15        2         23                  72         2                88-98      Portugal       B
  Quenzer\[[@B137]\]           72      R        Other                    N/A                             10       26       6         7         24                             33               69-72      USA            C
  Roca\[[@B138]\]              54      R        Duke                     NR         62        61         20       15       13        6         19                  20         22               99-04      Spain          B
  Romero-Vivas\[[@B139]\]      100     R        Von Reyn                            40                   23       30                           8                   7          24               77-82      Spain          C
  Rostagno\[[@B140]\]          86      P        Duke                     NR         59        65         20       5        13                  27       12                    35               03-06      Italy          B
  Ruiz\[[@B141]\]              168     R        Duke                     Pos        38        64         27       16       4         5         39                  21         13               92-97      Brazil         B
  Sanabria\[[@B142]\]          112     R        Other                    N/A                             40                                    7        13         12         5                81-86      USA            C
  Sandre\[[@B143]\]            135     R        Duke/Von Reyn            Pos                  65         27       4        10        6         10                  11         31               85-93      Canada         B
  Sarli-Issa\[[@B144]\]        703     P        Pelletier                N/A        36        66         19                          7         11                  6          31               78-98      Brazil         B
  Seibaek\[[@B145]\]           69      R        Other                    N/A        51        70         13                                    12                  6          29               83-92      Denmark        C
  Sekido\[[@B146]\]            38      R        Duke                     Def        43        66         13       34       8                   32       16                    3                86-96      Japan          B
  Shinebourne\[[@B147]\]       63      R        Other                    N/A                  69         3        40                 10        11                                              56-65      UK             C
  Shively \[[@B148]\]          16      P        Other                    N/A                             38       19                 6                             23         18               88-89      USA            C
  Siddiq\[[@B149]\]            182     P        Other                    N/A        46        63         57       21       3         7         4        9          67         9                90-93      USA            B
  Singhman\[[@B150]\]          101     R        Other                    N/A                  59         14       43                           24       23                    1                68-77      Malaysia       C
  Slipczuk                     261     R        Mod Duke                 Pos        60        49         48       10       7         20        4        25         15         11               00-10      USA            B
  Strate\[[@B151]\]            30      R        Other                    N/A        51        33         20       37       7         10        13                  0          10               75-84      Denmark        C
  Sucu\[[@B152]\]              72      R        Mod Duke                 Def        45        57         17       17       10        4         36       15                    29               04-07      Turkey         B
  Svanbom\[[@B153]\]           41      P        Other                    Prob       53                   22       32       2         7         5                                               67-71      Sweden         B
  Sy\[[@B154]\]                273     R        Mod Duke                 Pos        55        68         43       19       4         8         15       23         19         20               96-06      Australia      B
  Tariq\[[@B155]\]             66      R        Mod Duke                 Pos        24        67         5        18       8         2         48       27         2          8                97-01      Pakinstan      B
  Terpenning\[[@B156]\]        154     R        Von Reyn                 Prob                            36       26       9         10        3                   22         18               76-85      USA            B
  Thalme\[[@B157]\]            192     R        Duke                     Pos        52        55         36       21       10        10        14       9          31         15               94-00      Sweden         B
  Thornton\[[@B158]\]          139     R        Other                    N/A        41        61         24       36       1         13                            3          13               69-79      USA            C
  Tornos\[[@B159]\]            104     P        Mod Duke                 Pos        57        70         33       13                 14        14                  8          26               01         Europe         B
  Tran\[[@B160]\]              136     R        Duke                     Pos        54        61         24       28       9         12        18       15         13         21               98-00      Denmark        B
  Tugcu\[[@B161]\]             68      R        Mod Duke                 Pos        51        59         28       13       13        2         21       25         0          56               97-07      Turkey         B
  Venezio\[[@B162]\]           40      R        Other                    N/A                             15       35       3                                                  15               72-80      USA            C
  Verheul\[[@B163]\]           141     R        Von Reyn                 Pos        45        74         18       68                                                                           66-91      Netherlands    B
  Vlessis\[[@B164]\]           140     R        Von Reyn                 Pos        57        65         21                5         9                             11         22               82-92      USA            B
  Von Reyn\[[@B165]\]          104     R        Von Reyn                 Pos                  51         25       34       3         7         5                   4          21               70-77      USA            B
  Wang\[[@B166]\]              70      R        Duke                     x          36        54                  33                 7         40                             11               88-00      China          C
  Watanakukakorn\[[@B167]\]    210     R        Other                    N/A        65        55         47       14                 5                             16         14               80-90      USA            C
  Wells\[[@B168]\]             102     R        Von Reyn                 NR         52        64         27       43       3         4         5        27         4          9                79-86      NZ             B
  Welsby\[[@B169]\]            91      R        Other                    N/A        53        65         4        18       1                   11                                              59-74      UK             C
  Weng\[[@B170]\]              109     R        Duke                     Pos        38        73         15       22       1         2         49                  5          9                84-94      China          B
  Werner\[[@B171]\]            106     R        Duke                     Def        59                   18       28       14        17        13       20         5          26               89-93      Germany        B
  Witchitz\[[@B172]\]          228     NR       Von Reyn                 Prob                            36                                    9                                               81-88      France         B
  Witchitz\[[@B172]\]          257     NR       Von Reyn                 Prob                            30                          13        9                   9          22               73-80      France         B
  Wong\[[@B173]\]              57      R        Mod Duke                 Pos        66        77         28                7         10        12                             28               02-07      NZ             B
  Zamorano\[[@B174]\]          151     NR       Duke                     Def        51        66         31       13                           21                  27         33               91-03      Spain          B

Frequency distribution for pathogens, male, in-hospital mortality and, IVDA and prosthetic valve are expressed as percentage of total. De=Design. Cert= Diagnosis certainty. SA= Staphylococcus aureus. SV Strepcococcus viridans. CNS= Coagulase-negative Staphylococcus. Ent= Enterococci. CN= Culture negative. Mort= In-hospital mortality. IVDA= Intravenous drug abuse IE. Prosthetic= Prosthetic valve IE. P= Prospective. R=Retrospective. Def= Definite. Pos= Possible. Prob= Probable. NR= Not reported. N/A= Not applicable.

10.1371/journal.pone.0082665.t002

###### Characteristics of population-based studies included.

  **Author**                **N**   **De**   **Definition**       **Cert**   **Incidence**                **Case find**                             **Age**      **Male**      **SA**      **SV**      **CNS**      **Ent**      **Cn**      **Mort**      **IVDA**      **Prosth**      **Year**   **Country**   **Quality**
  ------------------------- ------- -------- -------------------- ---------- ---------------------------- ----------------------------------------- ------------ ------------- ----------- ----------- ------------ ------------ ----------- ------------- ------------- --------------- ---------- ------------- -------------
  Benes\[[@B175]\]          134     P        Mod Duke             Pos        3.4cases/100K/year           MD report hospital                        69           60            30          13          8            8            34                        8             8               07-08      Czech Rep     B
  Benn\[[@B176]\]           62      R        Von Reyn             NR         27 cases/millon/year         D/c statistics                            55           58            34          21          5            15           8                         5             13              84-93      Denmark       B
  Correa de Sa\[[@B177]\]   40      P        Mod Duke             Pos        5.0 to 7.9 cases/100K/year   Registry                                  71           50            30          30          20           8            5                                       18              01-06      USA           B
  Delahaye\[[@B178]\]       401     P        Von Reyn             Pos        22.4cases/millon/year        Questionnaire                             56           64            18          27          5            10           9           21            5             22              90-91      France        B
  Goulet\[[@B179]\]         288     P        Von Reyn             Pos        18cases/millon/year          Survey                                    50                         12          37          6            20           10                                      15              82-83      France        B
  Griffin\[[@B180]\]        37      R        Von Reyn             Pos        3.9 cases/millon/year        Registry                                                             33          35                       6            3                                                       70-81      USA           C
  Griffin\[[@B180]\]        21      R        Von Reyn             Pos        3.3 cases/millon/year        Registry                                                             38          43                                    10                                      0               60-69      USA           C
  Hoen\[[@B181]\]           390     P        Duke                 Def        31 cases/million/year        Survey                                    60           71            23          16          6            7            5           16            6             16              99         France        A
  Hogevik\[[@B182]\]        127     P,R      Mod Von Reyn         Pos        6.2 cases/100K/year          MD report hospital                        69           36            31          22          6            5            9           23            7             15              84-88      Sweden        B
  King\[[@B183]\]           75      P        Pelletier/Von Reyn   Pos        1.7 cases/100K/year          MD report hospital                        48           56            35          25          4            9            3                         17            19              85-86      USA           B
  Nakatani\[[@B184]\]       848     R        Other                N/A        NR                           Survey                                    55           61            17          32          9            7                                                    12              00-01      Japan         C
  Schnurr\[[@B185]\]        70      R        Other                N/A        NR                           Registry and hospitand records                         61            20          45          7            7            6                                                       73-76      Scotland      C
  Scudeller\[[@B186]\]      254     P        Mod Duke             Pos        4.21 cases/100K/year         MD report hospital                        67           67            18          17                       19           19                        2             32              04-08      Italy         B
  Smith\[[@B187]\]          78      R        Other                NA         16 cases/million/year        Registry                                               56            18          24                                    20                                                      69-72      Scotland      C
  Steckelberg\[[@B22]\]     68      NR       Mod Von Reyn         NR         4.2 cases/100K/year          Registry and hospital records                                        29          40          7            3            12          28            3             35              70-87      USA           B
  Tleyjeh\[[@B16]\]         48      P        Mod Duke             Pos        6.3-6.5 cases/100K/year      Registry and hospital records             64           71            29          42          4            8            0                         6             25              90-00      USA           B
  Tleyjeh\[[@B16]\]         34      P        Mod Duke             Pos        5.0-7.0 cases/100K/year      Registry and hospital records             57           71            20          47          15           6            0                                       29              80-90      USA           B
  Tleyjeh\[[@B16]\]         25      P        Mod Duke             Pos        5.3 - 6.0 cases/100K/year    Registry and hospital records             61           80            28          44          0            0            4                                       4               70-79      USA           B
  Van der Meer\[[@B188]\]   406     P        Von Reyn             Pos        15 cases/million/year        Survey                                    52           66            20          40                       5            1           20            7             20              86-88      Netherla      B
  Whitby\[[@B189]\]         71      R        Von Reyn             NR         NR                           Registry, MD report and medical records   51           68            13          42          4            9            17                                                      76-81      UK            B

Frequency distribution for pathogens is expressed as percentage of total. De=Design. Cert= Diagnosis certainty. SA= Staphylococcus aureus. SV Strepcococcus viridans. CNS= Coagulase-negative Staphylococcus. Ent= Enterococci. CN= Culture negative. Mort= In-hospital mortality. IVDA= Intravenous drug abuse IE. Prosth= Prosthetic valve IE. P= Prospective. R=Retrospective. Def= Definite. Pos= Possible. NR= Not reported. N/A= Not applicable.

Hospital-based Studies {#s3.1}
----------------------

Among hospital-based studies, IE epidemiology changed over the last 5 decades ([Figure 2](#pone-0082665-g002){ref-type="fig"}). Patients were significantly older ([Figure 2A](#pone-0082665-g002){ref-type="fig"}; 1980s: mean age 45.3, CI 40.2- 50.5 vs 2000s: mean age 57.2, CI 54.7- 59.7, p\<0.001), and more were men ([Figure 2B](#pone-0082665-g002){ref-type="fig"}; 1970s: 58.6%, CI 54.3- 63.0 vs 2000s: 66.3%, CI 63.6- 69.0, p\<0.01). The percentage of IE cases occurring on prosthetic valves increased over time though with borderline statistical significance ([Figure 2C](#pone-0082665-g002){ref-type="fig"}; 1960s: 8.4%, CI -3.8- 20.5 vs 2000s: 22.9%, CI 19.1 - 26.7, p=0.05).

![Epidemiology of Infective Endocarditis.\
Figure shows age (A), male percentage (B) or prosthetic valve IE (C) of patients in each decade (mean in green, centerline of diamond) and variance (as size of diamond) plus standard deviation (blue). Each dot in column represents a particular study mean. N below decades represents total number of patients in each decade. A) IE patients are older in the last two decades. B) Male to female ration increased in the last decade. C) No significant changes were found on prosthetic valve IE. However a trend towards an increase can be seen. \*= p\<0.05; \*\*=p\<0.01; \*\*\*=p\<0.001.](pone.0082665.g002){#pone-0082665-g002}

Changes in microbiology percentage over time are summarized in [Figure 3](#pone-0082665-g003){ref-type="fig"} and shown in e- [Figure 1](#pone-0082665-g001){ref-type="fig"} for individual organisms. There were significant increases in frequency distribution of *Staphylococcus aureus* (SA, [Figure 4A](#pone-0082665-g004){ref-type="fig"}) IE (1960s: 18.1% CI 9.4- 26.7 vs 2000s: 29.7%, CI 26.2- 33.3, p\<0.05) and coagulase-negative staphylococcus (CNS, [Figure 4B](#pone-0082665-g004){ref-type="fig"}) IE (1960s: 2.4%, CI 0.8-5.5 vs 2000s: 10.0%, CI 8.6-11.3, p\<0.01). Enterococcal IE percentage increased significantly over the last decade ([Figure 4C](#pone-0082665-g004){ref-type="fig"}, 1980s: 6.8%, CI 5.4- 8.2 vs 2000s: 10.5%, CI 8.9- 12.1, p\<0.001) while culture negative IE decreased in that time period ([Figure 4D](#pone-0082665-g004){ref-type="fig"}, 1980s: 23.1%, CI 15.0- 31.3 vs 2000s: 14.2% CI 9.9- 18.2; p=0.01). Streptococcus viridans (SV) IE markedly decreased in percentage over time span of the study ([Figure 4E](#pone-0082665-g004){ref-type="fig"}, 1960s: 27.4%, CI 18.4-36.4 vs 2000s: 17.6%, CI 15.7-19.5, p\<0.05).

![Summary of Worldwide Microbiology of Infective Endocarditis.\
Bars represent percentage of *Staphylococcus* *aureus* (SA) (light green), Streptococcus viridans (SV, dark green), enterococci (Entero, light blue), coagulase-negative staphylococcus (CNS, dark blue), and Culture negative (CN, white) endocarditis in each decade. \*= p\<0.05; \*\*=p\<0.01; \*\*\*=p\<0.001.](pone.0082665.g003){#pone-0082665-g003}

![Microbiology of Infective Endocarditis.\
Figure shows percentage of *Staphylococcus* *aureus* (SA) IE (A), coagulase-negative staphylococcus (CNS, B), enterococci (C), Culture negative (D) and Streptococcus viridans (SV, E) of patients in each decade (mean in green, centerline of diamond) and variance (as size of diamond) plus standard deviation (blue). Each dot in column represents a particular study mean. N below decades represents total number of patients in each decade. A) SA increased in the last decade. B) CNS increased over time. C) enteroccoci increased in the last decade. D) Culture negative endocarditis decreased in the last decade. E) SV decreased over time. \*= p\<0.05; \*\*=p\<0.01; \*\*\*=p\<0.001.](pone.0082665.g004){#pone-0082665-g004}

Subgroup analyses, by continent, were performed. The increase in overall SA frequency was driven by an increase in North America ([Figure 5A](#pone-0082665-g005){ref-type="fig"}; 1960s: 25.3%, CI 13.9- 36.6 vs 2000s: 52.4%, CI 42.4- 62.3, p=0.001). SA percentage in Europe remained stable over the last 4 decades ([Figure 5B](#pone-0082665-g005){ref-type="fig"}; 1970s: 25.1%, CI 18.2- 32.1 vs 2000s: 23.5%, CI 19.1- 28.0, p=0.70). No significant differences were found in SA IE frequency in Asia, Africa, Latin America, or Oceania.

![Regional Differences for Staphylococcus Aureus and Intravenous Drug Abuse.\
Figure shows percentage of *Staphylococcus* *aureus* (Staph, SA) IE in North America (A) or Europe (B) and intravenous drug abuse related IE in North America (C) and Europe (D), of patients in each decade (mean in green, centerline of diamond) and variance (as size of diamond) plus standard deviation (blue). N below decades represents total number of patients in each decade. A) SA increased markedly over last half century in North America B) No changes in SA were found in Europe. C) IVDA related IE frequency increased in North America. D) IVDA related IE percentage decreased in Europe in the last decade. \*= p\<0.05; \*\*=p\<0.01; \*\*\*=p\<0.001.](pone.0082665.g005){#pone-0082665-g005}

Counterbalancing the increase in SA IE percentage in North America was a decrease in SV IE frequency (1970s: 33.5%, CI 25.8- 41.3 vs 2000s: 14.4%, CI 5.6- 23.2, p\<0.01). SV IE frequency distribution also decreased significantly in Asia (1970s: 41.5%, CI 28.7- 54.4 vs 2000s: 10.1%, CI -8.9- 29.2, p\<0.01) while in Europe there was a decrease that did not reach statistical significance (p=0.06). No significant changes were seen in Latin America and Oceania (p=0.9, p=0.32, respectively). Insufficient data were available from Africa for separate analysis.

Subgroup analyses for changes in IVDA IE percentage are shown in [Figure 5](#pone-0082665-g005){ref-type="fig"}. No significant changes were seen on a global basis. However, a significant increase in IVDA related IE frequency distribution was observed in North America in the last decade ([Figure 5C](#pone-0082665-g005){ref-type="fig"}; 1980s: 17.3%, CI 10.7- 23.9 vs 2000s: 50.7%, CI 28.5- 73.0, p\<0.05). Conversely, we observed a significant decrease in IVDA related IE percentage in Europe in the last decade ([Figure 5D](#pone-0082665-g005){ref-type="fig"}; 1990s: 21.1%, CI 12.3- 29.8 vs 2000s: 6.8%, CI 3.5- 10.2, p\<0.01). We found a positive correlation between SA IE and IVDA. Interestingly, this correlation lost strength in the last decade (1990s rs=0.82, p=0.001 vs 2000s rs=0.40 p=0.05; 1990s vs 2000s, Fisher r-to-z transformation, p\<0.001). We further analyzed the studies that reported microbiology for the IVDA IE group. Twenty-five studies and 1288 patients were included in this sub-analysis. No significant temporal trends in IVDA IE microbiology were found. In this subset of patients, SA represented the main pathogen (1970s: 69.89 CI 31.40- 108.38, 1980s: 72.72 CI 57.98- 93.45, 1990s: 61.78 CI 47.87- 75.68 and 2000s: 65.99 CI 55.12- 76.86) and SV represented a small percentage of cases (1970s: 16.66 CI 3.87- 29.45, 1980s: 8.87 CI 2.79- 14.95, 1990s: 7.37 CI 3.57- 11.19, 2000s: 10.01 CI 7.21- 12.81).

In-hospital mortality rate due to IE decreased following the 1960s and remained stable thereafter ([Figure 6](#pone-0082665-g006){ref-type="fig"}; 1960s: 30.6%, CI 24.4- 36.8 vs 2000s: 19.7%, CI 17.8- 21.6, p=0.01). On subgroup analysis by continent, no regional differences were observed.

![In-Hospital Mortality of Infectious Endocarditis.\
Figure shows percentage of in-hospital mortality of Infectious Endocarditis in each decade (mean in green, centerline of diamond) and variance (as size of diamond) plus standard deviation (blue). Each dot in column represents a particular study mean. N below decades represents total number of patients in each decade. In-hospital mortality decreased after the 1960s and remained stable thereafter. ∗∗=p\<0.01.](pone.0082665.g006){#pone-0082665-g006}

Population-based Studies {#s3.2}
------------------------

Among population-based studies, no significant trends were observed regarding IE microbiology as shown in [Table 3](#pone-0082665-t003){ref-type="table"} (SA p=0.82; SV p=0.14; enterococci p=0.33). These studies included populations in the US and Europe primarily. Only one study was from Asia. Of note, the majority of data from the US is from Olmstead County, Minnesota.

10.1371/journal.pone.0082665.t003

###### Microbiology of Infective Endocarditis from Population-based Studies.

               **1960s**              **1970s**             **1980s**             **1990s**             **2000s**             **p**
  ------------ ---------------------- --------------------- --------------------- --------------------- --------------------- ----------
  **SA**       **38 % \[-1%-77%\]**   **22% \[12%-31%\]**   **21% \[15%-26%\]**   **21% \[14%-27%\]**   **19% \[13%-24%\]**   **0.82**
  **SV**       **43% \[-9%-95%\]**    **37% \[24%-50%\]**   **34% \[27%-42%\]**   **23% \[14%-31%\]**   **27% \[19%-33%\]**   **0.14**
  **Entero**                          **56% \[-3%-14%\]**   **13% \[8%-19%\]**    **8% \[3%-13%\]**     **9% \[5%-13%\]**     **0.33**

Among population-based studies, no significant changes were observed regarding infectious endocarditis microbiology incidence over last five decades. Note that percentages are weighted by size and therefore sum of each decade may exceed 100%.

2000s data from Einstein Medical Center, Philadelphia, PA, US {#s3.3}
-------------------------------------------------------------

We identified a total of 261 cases from 2000 to 2010 ([Table 4](#pone-0082665-t004){ref-type="table"}). Mean age was 59 and 49% were male. In-hospital mortality rate was 25⋅3%. Prosthetic IE represented 10.7% and IVDA 14.6%. SA was the primary IE microorganism seen causing 48.3% of IE \[25.3% Methicillin-sensitive *Staphylococcus aureus* (MSSA) and 23.0% Methicillin-resistant *Staphylococcus aureus* (MRSA)\] while CNS was seen in 6.9% of the cases. Enterococcus was the IE etiology in 19.2% and SV 9.6%. Culture negative IE represented 3.8%. Removal of this data did not modify overall results.

10.1371/journal.pone.0082665.t004

###### Data from Einstein Medical Center from 2000-2010.

  Cases            261
  ---------------- -----------
  Time frame       2000-2010
  Age              59.8
  Male             49.4%
  In-hosp mort     25.3%
  Prosthetic       10.7%
  IVDA             14.6%
  Staph aureus     48.3%
  MSSA             25.3%
  MRSA             23.0%
  Enterococci      19.2%
  Strep viridans   9.6%
  Coag Neg Staph   6.9%
  Culture neg      3.8%

Discussion {#s4}
==========

The main finding of this study is that the epidemiology of IE has changed worldwide over the last half century. Furthermore, the observed changes in IE microbiology varied by continent. These findings stemmed from analyses of hospital-based reports. In a separately analyzed smaller group of population-based studies (most of them from the US), no consistent changes in IE microbiology frequency distribution over time were observed.

Most notably, the global percentage of SA IE has nearly doubled in the last five decades (18% in the 1960s to nearly 30% in the 2000s). When analyzed by continent this increase was largely due to an increased frequency of SA in North America (from 25% in the 1960s to 52% in the 2000s) with no significant change among reports from other continents. This finding has important implications as SA infections are associated with longer length of stay, higher death rates\[[@B23]\], increase hospitalizations\[[@B24]\], and elevated costs\[[@B24]\]. An increase in IVDA IE percentage in North America as compared to Europe may partially explain these changes in SA frequency distribution. However, the number of studies in the last decade in this analysis is small and therefore this finding should be studied further. Other potential contributors include increases in the elderly population\[[@B10]\], increased numbers of chronically-ill patients\[[@B25]\], increased contacts with the health-care system\[[@B26],[@B27]\], and increasing use of intracardiac and vascular devices. Benito and colleagues\[[@B27]\] found a high percentage of health-care associated infections (related to catheters, dialysis, or immunosuppressive therapy) among US patients with native valve IE; SA was the most common organism isolated. Though the present study was not able to specifically track cardiac device implantation, another recent study found an increased prevalence of staphylococcal IE in these patients\[[@B28]\]. In absolute numbers Bor et al, reported an incidence of infective endocarditis in the US close to 40,000 cases/year \[[@B29]\]. Furthermore, at least when measured by ICD codes the total number of SA cases seems to be increasing in the US \[[@B15]\]. In addition, certain subgroups may behave differently; a well-designed population based study found that SA frequency has increased in Europe in patients without previously known valve disease\[[@B5]\]. It is important to clarify that changes in individual countries may not necessarily follow the trends at a continent level.

The present study also documents a substantial decline in the frequency of SV IE over the last five decades (27.4% in the 1960s to 17.6% in the 2000s). This finding was statistically significant for North America and Asia with a strong trend in Europe. Therefore, it appears that changes in the epidemiology of this organism are more widespread than for SA.

Paralleling the increase in SA IE frequency, there was also an increase in CNS IE percentage over time. It is known that CNS infections are often related to the use of intravascular catheters and prosthetic vascular grafts\[[@B30]\]. Thus, the rise in CNS IE may well be health-care related.

Enterococcal IE frequency increased in the last decade of the study. Enterococcal infections typically affect elderly patients and those with prior valvular damage, diabetes mellitus, indwelling catheters, or who are on hemodyalisis\[[@B31]\]. This finding is extremely important given the high prevalence of multidrug resistant enterococci and therefore the implications on treatment options. Lastly, culture negative endocarditis percentage decreased in the last decade. This is likely because of improved laboratory techniques and culture methods.

Worldwide, the present study found increases in age among IE patients. This has important implications for treatment and use of health care resources as elderly patients have more comorbidities and may be more prone to infection with certain organisms, such as enterococci. Consistent with the general perception\[[@B18]\], the present study found that in-hospital mortality rate of IE remains high with no significant decrease observed since the 1960s.

A limitation of the present study is the lack of individual patient level data. This data was not available from older studies and including it for only the last decades would have changed one bias for another one, without adding accuracy. Another limitation is that most of the findings come from hospital-based studies, whereas no significant changes were seen in the population based-studies over time. One possible explanation for this is a lack of power (18 population-based studies covering 3,477 patients vs 142 hospital-based studies covering 23,606 patients). Population-studies are also subject to sample bias: the population studied may not truly represent the general population. They can be subject to underreporting, as many times they rely on surveys. Moreover, population-studies of IE in the US are mainly from the Olmstead County, a population that is unlikely to represent the total US population. Hospital-based studies can suffer from referral bias as well, with sicker patients being referred to specialized centers. Thus, these results might not apply to community hospitals. However, Kanafani and colleagues\[[@B32]\] found only a slight difference between referred and non-referred patients, with higher SA IE in the non-referred patients. Thus, had this played a role in the present study, it would have likely decreased SA frequency. Therefore, it is unlikely to explain our findings. Finally, the definition of IE has changed over time, as well as culture quality, which could have caused heterogeneity in the cases included.

Conclusion {#s5}
==========

The present study represents the largest systematic review of IE epidemiology to date. Important findings include an increase in staphylococcal IE frequency over the last half-century, particularly in North America, and a worldwide decrease in SV IE percentage. In the last decade SA IE and enterococci IE frequencies have increased while culture negative IE has decreased. Patients with IE are getting older and the male to female ratio is increasing. Mortality has changed little in the last four decades.
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